» Articles » PMID: 7046453

Fibrin Deposits in Hodgkin's Disease

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1982 Jul 1
PMID 7046453
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Fibrin deposits were observed in the involved lymph nodes and/or spleens of 15 patients with Hodgkin's disease by specific immunofluorescence and by electron microscopy. Two basic patterns of fibrin deposition were observed: 1) intercellular deposits, chiefly associated with nonneoplastic-appearing lymphoid cells and 2) deposits associated with the collagen fibers of young connective tissue. In addition, coarse fibrin deposits were observed in areas of necrosis, presumably a non-specific finding. Fibronectin was also observed in intercellular areas, but staining was less intense than for fibrin. Fibrin deposits were also observed in 3 of 6 cases of non-Hodgkin's lymphoma, indicating that the finding is not an exclusive feature of Hodgkin's disease. The pathogenesis and possible significance of fibrin deposition in Hodgkin's disease are related to earlier observations of activation of the coagulation system on neoplasia and cell-mediated immunity and to the possible role of fibrin, fibronectin, and their breakdown products in angiogenesis and fibroplasia.

Citing Articles

Reconciling VEGF With VPF: The Importance of Increased Vascular Permeability for Stroma Formation in Tumors, Healing Wounds, and Chronic Inflammation.

Dvorak H Front Cell Dev Biol. 2021; 9:660609.

PMID: 33834026 PMC: 8021773. DOI: 10.3389/fcell.2021.660609.


Blood Coagulation Factor Fibrinogen in Tumor Pathogenesis of Central Nervous System B-Cell Lymphoma.

Chan J, Merlini M, Gao H, Mendiola A, Akassoglou K, Rubenstein J Am J Pathol. 2021; 191(3):575-583.

PMID: 33608067 PMC: 7919853. DOI: 10.1016/j.ajpath.2020.12.010.


Factor XIII-A in Diseases: Role Beyond Blood Coagulation.

Dull K, Fazekas F, Torocsik D Int J Mol Sci. 2021; 22(3).

PMID: 33535700 PMC: 7867190. DOI: 10.3390/ijms22031459.


Regulation of fibrin deposition by malignant mesothelioma.

Idell S, Pueblitz S, Emri S, Gungen Y, Gray L, Kumar A Am J Pathol. 1995; 147(5):1318-29.

PMID: 7485395 PMC: 1869523.


The distribution of fibronectin in lymph nodes infiltrated by Hodgkin's disease. An immunoperoxidase study on paraffin sections.

Moller P, Achtsatter H, Butzengeiger M, Schule B Virchows Arch A Pathol Anat Histopathol. 1983; 400(3):319-29.

PMID: 6412441 DOI: 10.1007/BF00612193.


References
1.
LUKES R, Butler J . The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966; 26(6):1063-83. View

2.
SPAR I, BALE W, MARRACK D, Dewey W, McCARDLE R, Harper P . 131-I-labeled antibodies to human fibrinogen. Diagnostic studies and therapeutic trials. Cancer. 1967; 20(5):865-70. DOI: 10.1002/1097-0142(1967)20:5<865::aid-cncr2820200546>3.0.co;2-5. View

3.
COOPER J, Haq B, Bagnell H . Intrafollicular hyalinosis and arterial hyalinosis of the spleen: histochemical and immunofluorescence studies. J Pathol. 1969; 98(3):193-9. DOI: 10.1002/path.1710980306. View

4.
PETERSON H, ZETTERGREN L . Thromboplastic and fibrinolytic properties of three transplantable rat tumours. Acta Chir Scand. 1970; 136(5):365-8. View

5.
HOLYOKE E, Frank A, WEISS L . Tumor thromboplastic activity in vitro. Int J Cancer. 1972; 9(2):258-63. DOI: 10.1002/ijc.2910090203. View